 BEIJING, Aug. 23, 2021 GLOBE NEWSWIRE -- Genetron Holdings Limited Genetron Health or the Company, Nasdaq: GTH, a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics development, today announced that management will host calls with various brokers following second quarter earnings and participate in an investor conference with Wells Fargo. 